Published in Herzschrittmacherther Elektrophysiol on December 01, 2010
A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol (1992) 12.18
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron (2000) 9.51
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med (1989) 9.08
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med (2009) 3.35
Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med (2004) 2.97
A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol (1984) 2.63
The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J (2003) 2.10
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA (1993) 1.60
Shortening of the action potential and reduction of pacemaker activity by lidocaine, quinidine, and procainamide in sheep cardiac purkinje fibers. An effect on Na or K currents? Circ Res (1982) 1.53
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol (1996) 1.47
Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Ann Emerg Med (2005) 1.40
Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3. Heart Rhythm (2008) 1.27
Complications in the catheter ablation of atrial fibrillation: incidence and management. Circ J (2009) 1.15
Fetal arrhythmia: prenatal diagnosis and perinatal management. J Obstet Gynaecol Res (2009) 1.07
Damage to the esophagus after atrial fibrillation ablation: Just the tip of the iceberg? High prevalence of mediastinal changes diagnosed by endosonography. Circ Arrhythm Electrophysiol (2010) 1.02
[Guidelines for catheter ablation]. Clin Res Cardiol (2007) 1.02
Amiodarone: a multifaceted antiarrhythmic drug. Curr Cardiol Rep (2006) 0.98
Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol (2001) 0.98
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol (2002) 0.98
Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation (1989) 0.95
Antiarrhythmic drugs. Br Med J (Clin Res Ed) (1983) 0.94
Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol (2003) 0.94
Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping. J Cardiovasc Electrophysiol (2003) 0.93
Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds. Pacing Clin Electrophysiol (1983) 0.92
A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. Circulation (1995) 0.91
Cardiodepressive effects of antiarrhythmic drugs. Eur Heart J (1989) 0.91
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group. Cardiovasc Drugs Ther (1996) 0.89
Proarrhythmia in a non-failing murine model of cardiac-specific Na+/Ca 2+ exchanger overexpression: whole heart and cellular mechanisms. Basic Res Cardiol (2012) 0.88
Ablation of right and left ectopic atrial tachycardias using a three-dimensional nonfluoroscopic mapping system. Am J Cardiol (1998) 0.88
Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol (1996) 0.87
Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. J Am Coll Cardiol (1992) 0.78
[New aspects of frequency-dependent effect of class 1 anti-arrhythmia drugs. A critical analysis of useful subclassification]. Z Kardiol (1991) 0.76
LQT3: who is at risk for sudden cardiac death? Heart Rhythm (2008) 0.76
Atrial fibrillation: Ablation of atrial fibrillation: for whom and how? Heart (2010) 0.76
Dronedarone: a promising alternative for the management of atrial fibrillation. Cardiovasc Drugs Ther (2009) 0.76
Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents. Postgrad Med J (1985) 0.75
Approach to wide complex tachycardias in patients without structural heart disease. Heart (2006) 0.75
A rational scientific basis for subclassification of antiarrhythmic drugs. Trans Am Clin Climatol Assoc (1986) 0.75
Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med (1999) 5.12
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol (2001) 2.40
Electrogram polarity and cavotricuspid isthmus block during ablation of typical atrial flutter. J Cardiovasc Electrophysiol (2001) 1.65
Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol (2001) 1.25
Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response. Heart (2004) 1.13
Role of transisthmus conduction intervals in predicting bidirectional block after ablation of typical atrial flutter. J Cardiovasc Electrophysiol (2001) 1.07
Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3. Basic Res Cardiol (2005) 1.05
Fetoscopic transesophageal electrocardiography and stimulation in fetal sheep: a minimally invasive approach aimed at diagnosis and termination of therapy-refractory supraventricular tachycardias in human fetuses. Circulation (1999) 1.04
Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.98
[Recommendations of the Working Group of Arrhythmias of the German Society of Cardiology on the approach to patients with Riata® and Riata ST® leads (St. Jude Medical). Nucleus of the Working Group of Arrhythmias of the German Society of Cardiology]. Herzschrittmacherther Elektrophysiol (2012) 0.97
The meaning of playing-related musculoskeletal disorders to classical musicians. Soc Sci Med (1998) 0.96
[Guideline invasive electrophysiological diagnostics]. Clin Res Cardiol (2007) 0.94
Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure. Br J Pharmacol (2012) 0.92
Complete atrioventricular block after valvular heart surgery and the timing of pacemaker implantation. Am J Cardiol (2001) 0.90
[How to approach the patient with supraventricular tachycardia in the EP lab: A systematic overview]. Herzschrittmacherther Elektrophysiol (2015) 0.88
Modification of stretch-induced shortening of repolarization by streptomycin in the isolated rabbit heart. J Cardiovasc Pharmacol (2000) 0.87
Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology (2002) 0.87
Alcohol consumption and other psycho-social conditions as important factors in the development of diabetic foot ulcers. Diabet Med (2011) 0.86
Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J (2001) 0.85
Effects of thoracic epidural anesthesia with and without autonomic nervous system blockade on cardiac monophasic action potentials and effective refractoriness in awake dogs. Anesthesiology (2001) 0.85
Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis. Coron Artery Dis (1998) 0.85
Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs. Basic Res Cardiol (1998) 0.85
Panic attacks and supraventricular tachycardias: the chicken or the egg? Neth Heart J (2013) 0.83
QT interval prolongation and risk for cardiac events in genotyped LQTS-index children. Eur J Pediatr (2008) 0.83
Neuropsychological impact of cerebral microemboli in ablation of atrial fibrillation. Clin Res Cardiol (2014) 0.82
Torsade de pointes induced by ajmaline. Z Kardiol (2001) 0.82
Idiopathic ventricular outflow tract arrhythmias from the great cardiac vein: challenges and risks of catheter ablation. Int J Cardiol (2013) 0.81
Near-infrared reflectance spectroscopy for noninvasive monitoring of metabolites. Clin Chem Lab Med (2000) 0.81
Microelectrophoretic application of putative neurotransmitters onto various types of bulbar respiratory neurons. Arch Ital Biol (1979) 0.81
[Totally subcutaneous cardioverter-defibrillator (S-ICD®) : recent experience and future perspectives]. Herz (2011) 0.81
Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation (2000) 0.80
Cervical intramedullar schistosomiasis as a rare cause of acute tetraparesis. Clin Neurol Neurosurg (2001) 0.80
[Current status and problems of the entirely subcutaneous ICD (S-ICD®)]. Herzschrittmacherther Elektrophysiol (2013) 0.79
Axiographic evaluation of mandibular mobility in children with angle Class-II/2 malocclusion (deep overbite). J Orofac Orthop (2000) 0.79
Molecular genetics of arrhythmias--a new paradigm. Z Kardiol (2000) 0.79
Incidence and clinical significance of inducible atrial tachycardia in patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol (2001) 0.79
[Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis]. Dtsch Med Wochenschr (2008) 0.78
Risk stratification in arrhythmogenic right ventricular cardiomyopathy. Herzschrittmacherther Elektrophysiol (2013) 0.78
Multislice cardiac spiral CT evaluation of atypical hypertrophic cardiomyopathy with a calcified left ventricular thrombus. J Comput Assist Tomogr (2000) 0.78
Intracardiac tuberculoma causing "idiopathic" ventricular tachycardia in a patient without detectable heart disease. J Cardiovasc Electrophysiol (2001) 0.78
Clinical value of electrocardiographic parameters in genotyped individuals with familial long QT syndrome. Pacing Clin Electrophysiol (2001) 0.78
[The ICD as primary prevention. Rare indications]. Herzschrittmacherther Elektrophysiol (2010) 0.78
Cocultures of fetal and adult cardiomyocytes yield rhythmically beating rod shaped heart cells from adult rats. In Vitro Cell Dev Biol Anim (1995) 0.77
Inter-alpha-trypsin inhibitor of human serum: an inhibitor of polymorphonuclear granulocyte elastase. Hoppe Seylers Z Physiol Chem (1983) 0.77
Gender and age differences in induced atrial fibrillation. Am J Cardiol (2001) 0.76
A patient with "atrial torsades de pointes". J Cardiovasc Electrophysiol (2000) 0.76
Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest. Am J Cardiol (1997) 0.76
Sertindole: cardiac electrophysiological profile. Int J Psychiatry Clin Pract (2002) 0.76
Atrioventricular nodal re-entrant tachycardia in a patient with Ebstein anomaly. Heart (2004) 0.75
[ICD programming : multicenter automatic defibrillator implantation trial - reduce inappropriate therapy (MADIT-RIT)]. Internist (Berl) (2013) 0.75
[Clinical aspects and molecular genetics of the Jervell- and Lange-Nielsen Syndrome]. Z Kardiol (2002) 0.75
[ECG changes in primary neurological disorders, systemic diseases and primary cardioymopathies]. Herzschrittmacherther Elektrophysiol (2013) 0.75
A new algorithm to determine complete isthmus conduction block after radiofrequency catheter ablation for typical atrial flutter. Am J Cardiol (1999) 0.75
Biomechanical analysis of arch-guided molar distalization when employing superelastic NiTi coil springs. J Orofac Orthop (1999) 0.75
[New knowledge in arrhythmogenesis--role of ion channels and genetic aspects]. Z Kardiol (2000) 0.75
Reproducible conversion from wide to narrow complex tachycardia: what is the mechanism? J Cardiovasc Electrophysiol (2000) 0.75
Transvenous ICD implantation after artificial tricuspid valve replacement. A new approach placing a transvenous ICD lead in the mid cardiac vein of the coronary sinus. Z Kardiol (2005) 0.75
[Catecholaminergic polymorphic ventricular tachycardia]. Herzschrittmacherther Elektrophysiol (2012) 0.75
[Right ventricular tachyarrhythmias--diagnostics and therapy]. Herzschrittmacherther Elektrophysiol (2005) 0.75
[New concepts in the therapy of atrial fibrillation]. Dtsch Med Wochenschr (2011) 0.75
Simultaneous in utero assessment of AV nodal and ventricular electrophysiologic parameters in the fetal sheep heart. Basic Res Cardiol (2001) 0.75
[Syncope of unknown origin in heart failure: which diagnostic possibilities should be considered today?]. Herz (2001) 0.75
[The ECG -- beyond the "big" issues]. Herzschrittmacherther Elektrophysiol (2013) 0.75
[The autonomic nervous system and cardiac arrhythmias]. Internist (Berl) (2002) 0.75
[Congenital and "acquired QT syndromes]. Herz (1999) 0.75
Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment. J Cardiovasc Pharmacol Ther (2000) 0.75
Prolonged QRS duration increases QT dispersion but does not relate to arrhythmias in survivors of acute myocardial infarction. Pacing Clin Electrophysiol (2001) 0.75
[Risk stratification after myocardial infarction. Different methods for the prediction of life-threatening arrhythmias]. Dtsch Med Wochenschr (1998) 0.75
[Biomechanical analysis of arch-guided molar distalization with super-elastic nickel-titanium springs]. Biomed Tech (Berl) (1998) 0.75
[Atrial fibrillation : new anticoagulants and antiarrhythmic drugs]. Herz (2012) 0.75
Inhibitory action of vagal nerve and spinal cord afferents on discharge pattern of bulbar respiratory modulated neurons. Arch Ital Biol (1980) 0.75
[Catheter ablation of electrical storm: ready for prime time?]. Herzschrittmacherther Elektrophysiol (2014) 0.75
Abundance of microembolic signals detected by transcranial doppler ultrasound in a patient with Eisenmenger's syndrome. Cerebrovasc Dis (1999) 0.75
Advantages and limitations of transgenic mice: the role of the Na+/Ca2+ exchanger in cardiac electrophysiology and arrhythmia. Curr Med Chem (2014) 0.75
[The relationships between the EMG excitation pattern of the masseter muscle and the facial skeletal morphology]. Fortschr Kieferorthop (1995) 0.75
[Fronto-temporo-sphenoidal craniotomy using the Yasargil method in operations of aneurysms and expanding lesions of basal areas of the brain]. Neurol Neurochir Pol (1979) 0.75
Indications for compensatory extractions in orthodontic space closure in the frontal segments. J Orofac Orthop (1996) 0.75
[Right ventricular arrhythmias]. Internist (Berl) (2004) 0.75
[Clinical aspects and molecular genetics of the long QT-syndrome]. Dtsch Med Wochenschr (1999) 0.75
[Alternating partial and complete arterioventricular block in severe toxic diarrhea]. Przegl Lek (1965) 0.75
Which gynecological and obstetric patients want to attend psychosomatic services? J Psychosom Obstet Gynaecol (2008) 0.75